Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Xenon (XENE), Biogen (BIIB)

Tipranks - Tipranks - Tue Apr 21, 3:22AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenon (XENE) and Biogen (BIIB) with bullish sentiments.

Claim 30% Off TipRanks

Xenon (XENE)

In a report released today, Myles Minter from William Blair reiterated a Buy rating on Xenon. The company’s shares closed last Friday at $59.70.

According to TipRanks.com, Minter is a top 100 analyst with an average return of 39.5% and a 62.9% success rate. Minter covers the Healthcare sector, focusing on stocks such as Contineum Therapeutics, Inc. Class A, CAMP4 Therapeutics Corporation, and Neumora Therapeutics, Inc. ;'>

Currently, the analyst consensus on Xenon is a Strong Buy with an average price target of $75.82.

See Insiders’ Hot Stocks on TipRanks >>

Biogen (BIIB)

In a report issued on April 17, Salveen Richter from Goldman Sachs maintained a Buy rating on Biogen, with a price target of $231.00. The company’s shares closed last Friday at $177.35.

According to TipRanks.com, Richter is a 4-star analyst with an average return of 11.4% and a 46.3% success rate. Richter covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, 4D Molecular Therapeutics, and Vertex Pharmaceuticals. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Biogen with a $206.61 average price target, implying a 17.2% upside from current levels. In a report issued on April 14, Piper Sandler also upgraded the stock to Buy with a $214.00 price target.

Read More on XENE:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).